Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Advances in Brief

Transforming Growth Factor-β1 Mediates Cellular Response to DNA Damage in Situ

Kenneth B. Ewan, Rhonda L. Henshall-Powell, Shraddha A. Ravani, Maria Jose Pajares, Carlos Arteaga, Ray Warters, Rosemary J. Akhurst and Mary Helen Barcellos-Hoff
Kenneth B. Ewan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rhonda L. Henshall-Powell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shraddha A. Ravani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Jose Pajares
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Arteaga
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ray Warters
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosemary J. Akhurst
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Helen Barcellos-Hoff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published October 2002
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Irradiated TGF-β1 +/− mammary gland shows reduced levels of active TGF-β1 and Smad 2/3. TGF-β1 +/− and +/+ mice were irradiated whole body to a dose of 5 Gy and killed 1 h later. A, false color digital micrographs of dual immunofluorescence of antigen-purified TGF-β1 antibody (red) and LAP antibody (green) visualized simultaneously with DAPI-stained nuclei (blue). Comparison of mammary gland tissue from irradiated TGF-β1 +/+ and +/− mice indicates that TGF-β1 immunoreactivity (yellow orange) is greater in TGF-β1 +/+ mice, whereas TGF-β1+/− mice show predominant LAP immunoreactivity (green). The prominent localization of TGF-β1 in the irradiated wild-type mice reflects radiation-induced activation (5) . Note that all cells stain with antibodies to LAP before radiation exposure (7) . B, false color digital micrographs of Smad 2/3 antibody (green) localized simultaneously with DAPI-stained nuclei (blue). Comparison of mammary gland cryosections from sham (a and c) or irradiated (b and d) TGF-β1+/+ (a and b) and +/− (c and d) mice indicates that IR induced significant Smad2/3 immunoreactivity. Immunofluorescence intensity was markedly reduced in irradiated TGF-β1 +/− mice.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    TGF-β1 gene dosage correlates with reduced apoptosis and cell cycle block in response to radiation. A, the frequency of apoptotic nuclei detected using terminal deoxynucleotidyltransferase-mediated nick end labeling reaction was determined in the mammary epithelium of TGF-β1 +/− and +/+ mice (means; bars, SE; n = 3 animals). Sham-irradiated (▪) and whole-body irradiated ( Embedded Image) wild-type mice were significantly different (t test; P = 0.02). The irradiated TGF-β1 heterozygote mice were not significantly different from sham-irradiated heterozygote mice but were significantly different from irradiated wild-type mice (t test; P = 0.006). Pregnant NIH/OlaHsd TGF-β1 +/− dams were irradiated whole body (5 Gy) on day 12.5 of gestation. Embryos irradiated in utero were collected 6 h after irradiation. Apoptotic nuclei were detected using the terminal deoxynucleotidyltransferase-mediated nick end labeling reaction in liver (B) and epidermis (C) from TGF-β1 +/+, +/−, and −/− embryos. Apoptosis was decreased in control TGF-β1 +/− and −/− embryo tissues. Significantly increased apoptosis was absent from both liver and epidermis of irradiated TGF-β1 +/− and −/− embryos. The frequency of cycling cells was detected using PCNA antibodies in sham-irradiated (▪) and irradiated ( Embedded Image) embryos. Radiation-induced cell cycle block was evidenced by a 2–3-fold reduction of PCNA-positive cells after irradiation in utero in the liver (D) and epidermis (E) from TGF-β +/+ and +/− embryos. The frequency of PCNA-positive cells was not significantly different between sham and IR embryos of −/− genotype, indicating abrogation of radiation-induced cell cycle block.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    p53 Ser-18P is induced in irradiated mammary epithelial cells. A, antibodies to Ser-18P p53 were used in Western blotting of total tissue protein extracts of irradiated BALB/c mammary tissue. No signal was evident in sham-irradiated tissue. A single band was detected at 1 h and was present up to 24 h after radiation exposure by Western blotting. B, false color images of immunofluorescence localization of p53 Ser-18 phosphorylation detected using secondary antibodies labeled with Alexa 488 (appears green/turquoise). Nuclei were counterstained with DAPI (blue). Immunofluorescence was absent from controls in which the primary antibody was deleted (a) and discernable in only a few epithelial cells in sham-irradiated tissue (b). Prominent nuclear immunoreactivity was evident throughout the epithelium from 1 h (c), 4 h (d), 15 h (e), and 24 h (g) after radiation exposure.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Decreased radiation-induced p53 Ser-18 P after irradiation and chronic or transient TGF-β1 depletion. A, Western blot of tissue extracts from wild-type (wt) or Tgfβ1 heterozygote (ht) mice sham and 1–6 h after IR. p53 Ser-18 phosphorylation was significantly reduced in Tgfβ1 +/− mice 1–6 h after IR. B, p53 Ser-18P was localized as indicated in Fig. 3 <$REFLINK> using cryosections of C57BL/6/129Sv TGF-β1 +/+ mice (a–c) or TGF-β1 +/− mice (d–f) subjected to sham exposure (a and d) or irradiated with 5 Gy, 1 h (b and e) or 6 h (c and f) before sacrifice. Nuclear localization of p53 Ser-18P 1 h after IR was significantly reduced in TGF-β1 +/− animals compared with wild-type animals. By 6 h, p53 Ser-18P was decreased in both genotypes. C, Western blot of tissue extracts from BALB/c adult female mice injected i.p. with an irrelevant IgG antibody as a control (C) or TGF-β1 neutralizing (N) antibody before irradiation. p53 Ser-18P was significantly reduced 1 h after IR when TGF-β1 neutralizing antibodies were administered before irradiation. D, nuclear immunolocalization of p53 Ser-18P was significantly reduced in animals treated with TGF-β neutralizing antibody. Mice received control (a and b) or TGF-β pan-isoform neutralizing monoclonal antibody (c and d) 3 h before sham exposure (a and c) or whole-body irradiation with 5 Gy (b and d). p53 Ser-18P was localized in cryosections as indicated in Fig. 3 <$REFLINK> .

PreviousNext
Back to top
Cancer Research: 62 (20)
October 2002
Volume 62, Issue 20
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Transforming Growth Factor-β1 Mediates Cellular Response to DNA Damage in Situ
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Transforming Growth Factor-β1 Mediates Cellular Response to DNA Damage in Situ
Kenneth B. Ewan, Rhonda L. Henshall-Powell, Shraddha A. Ravani, Maria Jose Pajares, Carlos Arteaga, Ray Warters, Rosemary J. Akhurst and Mary Helen Barcellos-Hoff
Cancer Res October 15 2002 (62) (20) 5627-5631;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Transforming Growth Factor-β1 Mediates Cellular Response to DNA Damage in Situ
Kenneth B. Ewan, Rhonda L. Henshall-Powell, Shraddha A. Ravani, Maria Jose Pajares, Carlos Arteaga, Ray Warters, Rosemary J. Akhurst and Mary Helen Barcellos-Hoff
Cancer Res October 15 2002 (62) (20) 5627-5631;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion cDNA for Cancer Gene Immunotherapy
  • NIMA-Related Protein Kinase 1 Is Involved Early in the Ionizing Radiation-Induced DNA Damage Response
  • 2-Arachidonoylglycerol
Show more Advances in Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement